HLA-B*1502 screening and toxic effects of carbamazepine [2]

New England Journal of Medicine

Volumn 365, Issue 7, 2011, Pages 672-673

  Liao, Wei Ping ^a   Shi, Yi Wu ^b   Min, Fu Li ^b  

^a GUANGZHOU MEDICAL UNIVERSITY   (China)

^b Key Laboratory of Neurogenetics and Channelopathies of Guangdong Province   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CARBAMAZEPINE; HLA B ANTIGEN; HLA B1502 ANTIGEN; UNCLASSIFIED DRUG; ANTICONVULSIVE AGENT; HLA B*1502, HUMAN; HLA-B*1502, HUMAN; PHENYTOIN;

CHINESE; GENETIC SCREENING; GENOTYPE; GEOGRAPHIC DISTRIBUTION; HUMAN; JAPANESE; LETTER; PRIORITY JOURNAL; STEVENS JOHNSON SYNDROME; TOXIC EPIDERMAL NECROLYSIS; ASIAN; CHEMICALLY INDUCED DISORDER; DRUG TOXICITY; GENETICS; NOTE; CAUCASIAN;

ANTICONVULSANTS; ASIAN CONTINENTAL ANCESTRY GROUP; CARBAMAZEPINE; DRUG TOXICITY; HLA-B ANTIGENS; HUMANS; PHENYTOIN; STEVENS-JOHNSON SYNDROME; EUROPEAN CONTINENTAL ANCESTRY GROUP; GENOTYPE;

EID: 80051842253     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMc1105467     Document Type: Letter

References (3)

1. Locharernkul C., Loplumlert J., Limotai C., et al. Carbamazepine and phenytoin induced Stevens-Johnson syndrome is associated with HLA-B*1502 allele in Thai population. Epilepsia 2008;49:2087-2091[Erratum, Epilepsia 2009;50:971.]
2. Tassaneeyakul W., Tiamkao S., Jantararoungtong T., et al. Association between HLA-B*1502 and carbamazepine-induced severe cutaneous adverse drug reactions in a Thai population. Epilepsia 2010;51:926-930
3. Chung W.H., Hung S.I., Chen Y.T. Genetic predisposition of life-threatening antiepileptic-induced skin reactions. Expert Opin Drug Saf 2010;9:15-21.